Overall market sentiment has been high on Satsuma Pharmaceuticals Inc (STSA) stock lately. STSA receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With STSA Stock Today?
Satsuma Pharmaceuticals Inc (STSA) stock is trading at $26.88 as of 2:35 PM on Thursday, May 21, a gain of $0.88, or 3.38% from the previous closing price of $26.00. The stock has traded between $24.66 and $27.80 so far today. Volume today is 35,727 compared to average volume of 41,719.
To see the top 5 stocks in the Biotechnology industry click here.
More About Satsuma Pharmaceuticals Inc
Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.
